Insider · CIK 0001700659
Steve Pakola
Files at RGNX (REGENXBIO Inc.). First filing Mar 12, 2026, latest Jul 6, 2026.
In brief
Steve Pakola files SEC Form 4 as officer at RGNX (REGENXBIO Inc.). Since Mar 12, 2026, Steve Pakola has reported 0 open-market buys worth $0 and 4 open-market sells worth $940k, the latest filed on Jul 6, 2026.
A track record needs three past buys with six months of prices behind them; Steve Pakola has 0, so none is measured yet.
The newest scored trade: sold $29k of RGNX on Jul 2, 2026, filed Jul 6, 2026, scored 0 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $940k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RGNX: REGENXBIO Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | REGENXBIO Inc. | $29k 2,161 shares | -1% | +135% from low-17% from high | |
| 6Weak | REGENXBIO Inc. | $689k 56,333 shares | -24% | +109% from low-26% from high | |
| 6Weak | REGENXBIO Inc. | $169k 15,309 shares | -6% | +35% from low-37% from high | |
| 2Weak | REGENXBIO Inc. | $53k 5,124 shares | -2% | +86% from low-38% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 1, 2026 | RGNX REGENXBIO Inc. | 43,206 0.08% of outstanding | $518k | Jul 1, 2026 | $385k |
| May 11, 2026 | RGNX REGENXBIO Inc. | 34,917 0.07% of outstanding | $368k | May 11, 2026 | $53k |
| Mar 10, 2026 | RGNX REGENXBIO INC | 5,124 0.01% of outstanding | $53k | Mar 10, 2026 | none |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 1, 2026 | RGNX REGENXBIO Inc. | FTax withholding Common Stock | -7,468 | $9.69 | $72k | 205,541 | Aug 4, 2026 |
| Jul 2, 2026 | RGNX REGENXBIO Inc. | MOption exercise Common Stock10b5-1 | +2,161 | $7.86 | $17k | 215,170 | Jul 6, 2026 |
| Jul 2, 2026 | RGNX REGENXBIO Inc. | SOpen-market sale Common Stock10b5-1 | -2,161 | $13.64 | $29k | 213,009 | Jul 6, 2026 |
| Jul 2, 2026 | RGNX REGENXBIO Inc. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -2,161 | $0.00 | $0 | 64,812 | Jul 6, 2026 |
| Jun 29, 2026 | RGNX REGENXBIO Inc. | SOpen-market sale Common Stock10b5-1 | -19,608 | $11.04 | $216k | 213,009 | Jul 1, 2026 |
| Jul 1, 2026 | RGNX REGENXBIO Inc. | MOption exercise Common Stock10b5-1 | +36,725 | $7.86 | $289k | 249,734 | Jul 1, 2026 |
| Jul 1, 2026 | RGNX REGENXBIO Inc. | SOpen-market sale Common Stock10b5-1 | -36,725 | $12.86 | $472k | 213,009 | Jul 1, 2026 |
| Jul 1, 2026 | RGNX REGENXBIO Inc. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -36,725 | $0.00 | $0 | 66,973 | Jul 1, 2026 |
| May 11, 2026 | RGNX REGENXBIO Inc. | SOpen-market sale Common Stock10b5-1 | -15,309 | $11.02 | $169k | 232,617 | May 13, 2026 |
| Mar 10, 2026 | RGNX REGENXBIO Inc. | SOpen-market sale Common Stock10b5-1 | -5,124 | $10.35 | $53k | 247,926 | Mar 12, 2026 |
| Feb 1, 2026 | RGNX REGENXBIO Inc. | FTax withholding Common Stock | -5,267 | $11.16 | $59k | 253,050 | Feb 3, 2026 |
| Jan 6, 2026 | RGNX REGENXBIO Inc. | AGrant or award Common Stock | +65,847 | $0.00 | $0 | 258,317 | Jan 8, 2026 |
| Jan 6, 2026 | RGNX REGENXBIO Inc. | AGrant or award Stock Options (Right to buy)derivative | +35,402 | $0.00 | $0 | 35,402 | Jan 8, 2026 |
| Jan 2, 2026 | RGNX REGENXBIO Inc. | FTax withholding Common Stock | -18,247 | $14.40 | $263k | 192,470 | Jan 6, 2026 |
| Feb 1, 2025 | RGNX REGENXBIO Inc. | FTax withholding Common Stock | -5,263 | $8.07 | $42k | 210,717 | Apr 4, 2025 |
Questions about Steve Pakola
Answered from the filings on this page, as of the latest one.
Is Steve Pakola buying or selling?
In the last 12 months Steve Pakola reported 0 open-market buys worth $0 and 4 open-market sells worth $940k on SEC Form 4; the latest was sold $29k of RGNX on Jul 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Steve Pakola's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steve Pakola has 0.
Where does Steve Pakola file Form 4?
Steve Pakola has filed Form 4 at RGNX (REGENXBIO Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.